Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.180
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Biomerica Revenue
Biomerica had revenue of $987.00K in the quarter ending February 28, 2026, a decrease of -11.80%. This brings the company's revenue in the last twelve months to $4.33M, down -23.79% year-over-year. In the fiscal year ending May 31, 2025, Biomerica had annual revenue of $5.31M, down -1.92%.
Revenue (ttm)
$4.33M
Revenue Growth
-23.79%
P/S Ratio
1.56
Revenue / Employee
$80,130
Employees
54
Market Cap
6.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 5.31M | -104.00K | -1.92% |
| May 31, 2024 | 5.42M | 76.00K | 1.42% |
| May 31, 2023 | 5.34M | -13.53M | -71.71% |
| May 31, 2022 | 18.87M | 11.67M | 162.13% |
| May 31, 2021 | 7.20M | 506.32K | 7.57% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beyond Air | 6.92M |
| Tenon Medical | 3.94M |
| Intelligent Bio Solutions | 3.58M |
| Sintx Technologies | 1.02M |
| Co-Diagnostics | 622.49K |
| iTonic Holdings | 523.03K |
| Tivic Health Systems | 482.00K |
| Nexalin Technology | 301.65K |
BMRA News
- 12 days ago - Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway - GlobeNewsWire
- 14 days ago - Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - GlobeNewsWire
- 15 days ago - Biomerica Reports Third Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - GlobeNewsWire
- 7 weeks ago - Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain - GlobeNewsWire
- 2 months ago - Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - GlobeNewsWire
- 2 months ago - Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution - GlobeNewsWire
- 3 months ago - Biomerica Reports Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire